Zhang et al. found that pancreatic ductal adenocarcinoma (PDAC) patients with increased PD-L2 expression had reduced OS in comparison to those with a lower PD-L2 level in the tumor tissue [42]. The gene discussed is PDCD1LG2; the disease is pancreatic ductal adenocarcinoma.